| IBV | infectious bronchitis vaccine; infectious bronchitis virus |
|---|---|
| IPV | inactivated poliomyelitis vaccine or virus; infectious pustular vaginitis; infectious pustular vulvo... |
| KMV | killed measles virus vaccine |
| LVV | left ventricular volume; Le Veen valve; live varicella vaccine; live varicella virus |
| PLV | partial liquid ventilation; poliomyelitis live vaccine; panleukopenia virus; phenylalanine, lysine, ... |
| influenza C | Influenza caused by strains of type C influenza virus; the disease is milder than that caused by types A and B and has become uncommon in recent years. (05 Mar 2000) |
|---|---|
| influenza meningitis | <pathology> A form of meningitis caused by the bacterium haemophilus influenza. Inflammation of the membranes (meninges) covering the brain and spinal cord can result after infection with this organism. Influenza meningitis occurs most frequently in children under 5 years old. Onset may be sudden or occur more slowly after an upper respiratory infection. Symptoms and features include fever, headache, stiff neck, photophobia and mental status changes. Infants may be irritable and exhibit poor feeding associated with fever. Severe cases may progress to seizures, coma and death. Treatment always includes high-dose systemic antibiotics and corticosteroids may also be used in some select cases. (27 Sep 1997) |
| influenza nostras | Influenza, usually of a less severe type, occurring with some degree of regularity during the winter season, especially in the larger cities of the world. Synonym: influenza nostras. (05 Mar 2000) |
| influenza type a | A common acute viral infection of the nasopharynx and respiratory tract which occurs in epidemic forms. A common cause is the Influenza a virus. Annual vaccination is recommended for those in high risk groups (health care workers, elderly and immunocompromised) for influenza infection. Common symptoms include runny nose, fever, weakness, headache, body aches, muscle aches, nausea and back pain. Treatment of symptoms has been successful with amantadine or rimantadine. (27 Sep 1997) |
| influenza viruses | Virus's of the family Orthomyxoviridae which cause influenza and influenza-like infections of humans and other animals; virus's included are influenza virus types A and B of the genus Influenzavirus, causing, respectively, influenza A and B, and influenza virus type C, which probably belongs to a separate genus and causes influenza C. (05 Mar 2000) |
| endemic influenza | Influenza, usually of a less severe type, occurring with some degree of regularity during the winter season, especially in the larger cities of the world. Synonym: influenza nostras. (05 Mar 2000) |
| equine influenza | <veterinary, virology> A highly contagious upper respiratory infection of horses and other equids caused by equine strains of influenza virus type A. It is characterised by fever and respiratory signs similar to but more severe than those of equine rhinopneumonitis; oedema of the lower trunk and limbs (epizootic cellulitis) may occur; the disease is frequently fatal when secondary bacterial pneumonia intervenes. (05 Mar 2000) |
| bovine virus diarrhoea virus | A virus of the genus Pestivirus, in the family Togaviridae, causing bovine virus diarrhoea; New York, Oregon, and Indiana strains of the virus are recognised. Synonym: mucosal disease virus. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
| bacillus Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| BCG vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |